Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001628280-26-047058 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
103,197
Total Value
$627,917.43
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 28,826 | $1.01 | $29,114.26 | 168,198 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jun 30, 2026 | Sale | 28,826 | $16.04 | $462,288.33 | 139,372 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 4,183 | $1.01 | $4,224.83 | 143,555 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jul 1, 2026 | Sale | 5,852 | $15.67 | $91,681.53 | 137,703 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Jul 1, 2026 | Sale | 2,501 | $16.24 | $40,608.49 | 135,202 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 28,826 | $0.00 | $0.00 | 38,480 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 4,183 | $0.00 | $0.00 | 34,297 | Direct | โ | View Details |